Who is sponsoring NCT05941455?

NCT05941455 is sponsored by Jilin Venus Haoyue Medtech Limited.

What drugs are being tested in NCT05941455?

Interventions in NCT05941455: Venus-Neo Surgical Aortic Valve.

What condition does NCT05941455 study?

NCT05941455 studies Aortic Valve Disease, Cardiovascular Diseases.

Is NCT05941455 still recruiting?

NCT05941455 is currently not yet recruiting. Last updated 12 July 2023.

Last reviewed 2023-07-12 · How we verify

NCT05941455: METASAR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve

Not yet recruiting NA Last updated 12 July 2023

What this trial tests

NA trial testing Venus-Neo Surgical Aortic Valve in Aortic Valve Disease in 155 participants. Not yet recruiting.

Timeline

31 October 2023

Primary endpoint
31 October 2025

31 October 2029

Quick facts

Lead sponsor	Jilin Venus Haoyue Medtech Limited
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	155
Start date	31 October 2023
Primary completion	31 October 2025
Estimated completion	31 October 2029
Sites	1 location across Germany

Drugs / interventions tested

Venus-Neo Surgical Aortic Valve

Conditions studied

Aortic Valve Disease — all drugs for Aortic Valve Disease →
Cardiovascular Diseases — all drugs for Cardiovascular Diseases →

Sponsor

Jilin Venus Haoyue Medtech Limited

Who can join

18 and older, any sex, with Aortic Valve Disease or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the safety, effectiveness, and performance of Venus-Neo Surgical Aortic Valve in subjects who are clinically indicated for aortic valve replacement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Valve Disease

Currently open trials in the same condition.

NCT07008911 — CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation · NA · recruiting
NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease · recruiting
NCT07021612 — A Clinical and Imaging Registry of Transcatheter Aortic Valve Implantation Using JenaValve System/ J-Valve System for Pa · recruiting
NCT06896227 — TAVR: The Impact of Prothesis Positioning on Valvular and Coronary Hemodynamics · NA · recruiting
NCT06189976 — Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05941455 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jilin Venus Haoyue Medtech Limited
Last refreshed: 12 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05941455.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing